As featured in
The Managing Director of a private limited company is often the single point of failure. When she dies, retires or becomes incapacitated, the company's ability to sign cheques, enter into contracts, file returns and take strategic decisions can grind to a halt within days. Yet most Indian promoter families treat MD succession as an afterthought — with no articles amendments, no shareholders' agreement, no successor training. This guide walks through the Companies Act 2013 framework, the articles and shareholders'-agreement drafting that actually protects the business, the ROC filings that must happen post-death, and the common failure modes we see in practice.
A Managing Director appointed under Section 196 of the Companies Act 2013 is not just a family designation — she is a key managerial personnel (KMP) with statutory powers, statutory liabilities, and statutory reporting obligations to the Registrar of Companies. Her signature binds the company on contracts, banking mandates, statutory filings and tax returns. Her presence on the board is often required for the board to be quorate. Her authority is often the single authority under which the company's day-to-day operations run.
When an MD dies suddenly, three problems cascade. First, the company's banking mandates typically require a resolution of the board — but the board itself may not have quorum to pass such a resolution if the deceased was one of only two directors. Second, contracts, purchase orders, and vendor payments that require MD authorisation freeze. Third, any statutory filing due within the death window — Form DPT-3, Form AOC-4, annual return — may not be signed. The company can miss deadlines, attract penalties, and even face director-disqualification proceedings.
None of this is prevented by having a Will. A Will disposes of the deceased's individual property (shares she held personally). It does not automatically appoint a successor MD, does not amend the articles of association, and does not update banking mandates. Corporate governance instruments — articles, shareholders' agreement, board resolutions, delegated authorities — must do that work, in parallel with the personal Will.
The families we see get this right treat MD succession as a two-year, multi-instrument project: (a) redraft articles of association to have proper succession mechanisms, (b) execute a shareholders' agreement with the founder's family and other shareholders that binds them to a specific succession approach, (c) train the successor into a Whole-Time Director role for 12-24 months before the founder steps back, (d) coordinate all of this with individual Wills so that inheritance of shares aligns with the corporate succession plan.
Section 196 of the Companies Act 2013 governs the appointment of a Managing Director. An MD is appointed by the board of directors, subject to the approval of the general meeting where required. For a private limited company, the appointment of an MD is generally within the board's authority unless the articles require shareholder approval.
Section 203 requires certain companies (specifically listed companies and large public companies with paid-up capital above ₹10 crore) to have specific KMP — Managing Director or CEO, Company Secretary, and Chief Financial Officer. Private companies are exempted from mandatory KMP requirements, though many voluntarily appoint MDs for governance clarity.
Section 168 governs resignation of directors. A director may resign by giving notice in writing to the company. The resignation takes effect from the date on the notice or the date it is received, whichever is later. Form DIR-11 must be filed with the ROC within 30 days.
Section 167 covers vacation of office — an MD's office is deemed vacated on specified events including insolvency, unsound mind declared by court, absence from all meetings for 12 months, and death. Death is a vacancy event under Section 167(1)(g) read with succession jurisprudence.
Section 161(4) covers casual vacancy in the board — where a director of a company (whose appointment was approved by members in general meeting) dies or resigns, the board may fill the casual vacancy at a board meeting. The person so appointed holds office only until the term of the original director would have expired, subject to shareholder ratification at the next general meeting.
The articles of association (AoA) are the single most important document for MD succession. Yet in most Indian private limited companies with promoter-family control, the articles are the standard Table F template from Schedule I of the Companies Act 2013 — completely silent on MD succession, casual vacancy, and family-designation rules.
A proper articles amendment for a promoter-family company should specify: (a) the number of directors the company will have; (b) how directors are appointed and reappointed; (c) how casual vacancies are filled (including whether the deceased director's family has a right to nominate a successor); (d) whether specific family members can be permanent directors or life-directors under the articles; (e) how the Managing Director is appointed, and what threshold of board consent is required; (f) whether specific decisions require unanimous board approval or supermajority; (g) how deadlocks are resolved.
For families where the founder wants to ensure a specific child succeeds as MD, the articles can include a 'right of first refusal' clause for the founder's designated successor — the board must first consider the designated successor before appointing anyone else, and the founder's family retains the right to veto external appointment for a specified period after founder's death.
Articles amendments require special resolution — approval of at least 75% of the members present and voting at a general meeting. For promoter families with concentrated shareholding, this is typically achievable. For companies with external investors, the shareholders' agreement often specifies how the articles can be amended, and investors' consent may be required.
For companies where investors, non-family shareholders, or minority family members hold equity, a shareholders' agreement (SHA) sits alongside the articles and governs the shareholders' obligations to each other. On MD succession, the SHA typically addresses: buy-sell provisions for shares of a deceased shareholder; drag-along and tag-along rights; anti-dilution mechanisms; and board composition rules.
A well-drafted SHA for a founder-family company includes MD succession provisions: (a) the founder's right to designate her successor as MD in a written notice deposited with the company secretary; (b) the successor's automatic elevation to MD upon the founder's death, subject to being 25+ years old and holding minimum specified shareholding; (c) a supermajority requirement for removing the family-designated MD in the first 5 years after transition; (d) mandatory retention of family-designated director on the board even if MD role is vacated.
Coordination between the SHA and the articles is critical. The SHA is contractual (binds only the parties to it). The articles are constitutional (bind all shareholders, present and future). Where the SHA and articles conflict, the articles prevail in dealings with third parties. So SHA provisions must be reflected in the articles to have full force.
For families with substantial company value, SHA drafting is not a standalone task — it needs to be coordinated with individual Wills (so shares pass to persons contemplated by the SHA), the family constitution (so family behavioural expectations align), and the tax planning (so succession structure is tax-efficient across generations). This is Personalised Will or Succession Planning territory.
When a Managing Director dies, the first 72 hours are critical. The company's operations, banking, and regulatory obligations continue running while the family and remaining directors process the loss. Actions in this window prevent the death from becoming a governance crisis.
Day 1 — notify the company secretary or accountant immediately, before any operational communication goes out. The board should hold an emergency meeting (physical or virtual) to acknowledge the death, note the vacancy under Section 167, and appoint a temporary Chairman to manage administrative continuity.
Day 2-3 — check banking mandates. Most bank mandates require the MD's signature or specify her as authorised signatory. If she was the sole authorised signatory, the bank will freeze operations until the board designates a replacement via board resolution. Get this resolution passed and delivered to the bank immediately.
Day 4-7 — file Form DIR-12 with the ROC to notify the vacancy. This is mandatory within 30 days but should be done immediately for regulatory clarity. Simultaneously, the board must appoint a successor MD if the articles require an MD (or if the company's operations depend on one) — this is usually the family-designated successor per the SHA or articles.
Weeks 2-4 — coordinate with the family on personal-side actions: probate application for the deceased's shares (if a Will exists), death certificate registration on the deceased's individual holdings, notification to insurance providers, and update of banking mandates on any accounts where the deceased was joint-holder.
Under Section 161(4), the board can fill a casual vacancy caused by a director's death. The person so appointed holds office only until the original director's term would have expired — meaning the appointment is subject to shareholder ratification at the next AGM.
For family-designated successors, this creates a two-step process: (a) the board appoints the successor as a casual-vacancy director immediately after the death; (b) at the next AGM, shareholders ratify the appointment for the full term. Where the family holds majority shareholding, this ratification is typically automatic — but for companies with investors, the ratification vote can be a battleground.
The Managing Director role is separate from the directorship. Even after the successor is appointed as a director filling the casual vacancy, the board must separately pass a resolution appointing her as MD under Section 196. This is where articles matter — if the articles specifically empower the family to nominate the MD, the board must honour that nomination.
Board composition post-death can shift in unintended ways. If the founder-MD was also holding the position of Chairman, that role becomes vacant too. If the founder held nominee shares or was a Whole-Time Director, all those positions vacate. The board should audit all positions the deceased held (directorships, KMP roles, committee memberships, statutory-authority nominations) and fill each systematically.
The Registrar of Companies (ROC) requires specific notifications on director changes. Key filings after MD death:
Form DIR-12 — notification of change in directors, filed within 30 days of the vacancy. Filed by the company (not by the individual director). Includes death certificate as attachment.
Form DIR-11 — notification of cessation of directorship, typically filed by the resigning director. For death cases, this is not strictly required (Form DIR-12 by the company covers it) but some companies file both for completeness.
MGT-14 — filing of the board resolution appointing the successor MD, if the appointment required special resolution under Section 196. For private companies with standard articles, MD appointment is usually a board decision not requiring MGT-14.
PAS-3 — filing for any share transmission or transfer following the death, if the company issues fresh shares or transfers the deceased's shares.
Annual return (MGT-7A for small companies, MGT-7 for others) — the next annual return will reflect the change in directors and MD. Prepare the deceased's exit and the successor's entry properly in the annual return.
Failure to file these on time attracts penalties — currently ₹100 per day for late filing, with substantial cumulative liability if delays extend for months. The company secretary or the accountant should have a checklist ready.
The MD's personal Will determines who inherits her shares in the company. The corporate structure determines who runs the company. These two must align.
Common misalignment: the Will bequeaths shares equally to three children, but only one child is being trained to run the business. The other two inherit substantial equity but no operational role. Over time, this creates governance friction — non-operational shareholders may want dividends over reinvestment, may object to management decisions, may even demand buyout at premium valuations.
Better structures: (a) bequeath the MD's shares to a family trust with the operating child as trustee, so operational control is centralised; (b) create two classes of shares — voting shares to the operating child, non-voting economic-interest shares to the other children; (c) use family settlement mechanisms during the founder's lifetime to establish the equity split before death, giving all children input into the terms.
The individual Will drafting for a company MD should specifically address shareholding disposition, executor authority to manage shareholding during administration, and directions to file the necessary corporate paperwork to reflect transmission of shares to beneficiaries. Standard-template Wills miss all of this.
The deceased was the sole authorised bank signatory — bank operations freeze for weeks. Prevention: always have at least two authorised signatories on all critical bank accounts.
The deceased held a Whole-Time Director role that wasn't documented in the succession plan — the WTD position vacates unexpectedly, statutory compliance requirements can't be met. Prevention: maintain a role inventory of all positions the founder holds, and specify successor for each in the SHA or a supplementary document.
The successor was named in the SHA but never trained in operational matters — after the founder's death, the successor takes over but lacks context, vendor relationships, or operational knowledge. Prevention: 12-24 month formal transition plan with the successor shadowing the founder in all key areas.
The articles were never amended from Table F defaults — Section 161(4) applies, and the family-designated successor is subject to shareholder ratification, which becomes a fight. Prevention: articles amendments early, not late.
The deceased's Will bequeathed shares to persons not contemplated by the SHA — the SHA's transfer restrictions are triggered, share transmission becomes a legal battle. Prevention: draft the Will with the SHA in front of you; align disposition with SHA-permitted transferees.
Multiple family members claim they were verbally promised the MD role — no documentation, so disputes escalate to litigation. Prevention: written designation, deposited with company secretary, referenced in the shareholders' agreement.
For a company with a single family shareholder and only self-drafted articles — Personalised Will (₹25,000) is the right starting tier. The advocate will coordinate the founder's individual Will with the essential corporate documents.
For a family business with substantial value, multiple shareholders, and existing SHA — Succession Planning (₹1,00,000) is appropriate. The 12-month engagement covers articles amendments, SHA drafting, family constitution, individual Wills for founder and successor, and coordination with company secretary and chartered accountant.
For public-facing companies, listed group affiliates, or companies with substantial investor equity — engage specialist corporate counsel alongside our succession planning team. The complexity is real and off-the-shelf drafting is inadequate.
The 2016 Reliance Industries transition — Mukesh Ambani stepping back from operational MD role and elevating Isha and Akash Ambani into leadership positions across Jio and retail businesses — is India's most publicly-observed promoter succession. What is instructive for smaller family businesses is the multi-year runway: the succession was signalled to markets years in advance, next-generation members held operational roles under formal titles for extended periods before elevated responsibilities, and the transition happened without market disruption or governance uncertainty. The Reliance example shows how deliberate signalling, formal role progression, and family constitution alignment prevent the succession event itself from becoming a crisis.
The Tata Sons chairmanship dispute (2016-2017 Cyrus Mistry removal, 2019 restoration and 2021 conclusion) illustrates the opposite lesson — what happens when succession-adjacent governance is contested. The Tata Trusts + Tata Sons structure, articles-of-association provisions, and shareholders' agreement provisions all came under Supreme Court scrutiny. For promoter-family companies, the case is a reminder that even the most established structures can be tested; the strength of formal governance instruments determines whether disputes get resolved cleanly or drag through years of litigation.
The Bajaj family transition following Rahul Bajaj's death in February 2022 was smoother because roles had been distributed years earlier. Rajiv Bajaj (Bajaj Auto MD), Sanjiv Bajaj (Bajaj Finserv Chairman), Madhur Bajaj on family council — each had operational responsibility long before founder death. Family constitution provisions handled inter-branch coordination.
The private-company lesson from these case studies: succession is a multi-year process, not a moment. Formal governance instruments (articles, SHA, family constitution) provide the structure that decision-making follows. Legal drafting alone does not create succession — it creates the framework within which trained successors execute succession. For families reading this today: what would happen at your company tomorrow if the founder died tonight? If the answer involves uncertainty, this is your signal to begin formal succession planning.
Beyond the MD role itself, most private companies with mature governance have board committees — Audit Committee, Nomination and Remuneration Committee, Stakeholder Relationship Committee, and (for larger companies) Corporate Social Responsibility Committee. These are mandatory for listed companies under SEBI LODR and Companies Act 2013; many private companies voluntarily maintain committee structures for governance discipline.
On founder-MD death, all committee memberships that the deceased held become vacant. If the deceased chaired the Audit Committee, a new chair must be selected. If the deceased was the only independent-professional member of a committee, statutory composition requirements may temporarily fall out of compliance. The board should audit committee memberships within 30 days and reconstitute as needed.
For family-owned companies without external independent directors, the committee structure is often informal. Post-founder-death, the family should consider whether adding professional independent directors would strengthen governance during the transition period. The Companies Act permits private companies to voluntarily bring in independent directors even where not mandatory — this signals to lenders, vendors, and any external stakeholders that governance is being professionalised.
Committee meeting cadence often needs adjustment during transition. Where the founder-MD was chairing weekly management review meetings, the successor may need to establish a different rhythm — perhaps bi-weekly meetings with different agenda structure — reflecting the successor's operating style. The transition period (typically 6-12 months) is when new operating rhythms establish themselves; premature institutionalisation of the founder's specific patterns can lock in what may not fit the successor.
Founder-MD death triggers work across multiple professional advisors simultaneously — advocate for probate and succession, chartered accountant for tax filings, company secretary for ROC compliance, banker for account restructuring, insurance advisor for policy claims, wealth manager for investment portfolio, sometimes tax counsel for cross-border implications if the deceased had foreign assets. Coordinating this network is the successor's first executive test.
Best practice: designate a single coordinating advisor — typically the family's senior advocate — as the transition project manager. This person maintains the master timeline, checks that filings are on track, coordinates advisor-to-advisor communications, and reports weekly to the family. Ad hoc self-coordination by the family typically results in missed deadlines, duplicated work, and information asymmetries.
For substantial estates, a written 'succession runbook' prepared in advance is invaluable. The runbook lists: names and contact details of all advisors; account details and passwords (stored securely); insurance policies; company structures; property titles; digital asset access; and a week-by-week action plan for the first 90 days after death. Preparing this runbook is uncomfortable — it forces the founder to imagine their own death — but the delta between families with and without runbooks is substantial.
Law Tarazoo's Succession Planning tier (₹1,00,000) includes runbook preparation as a deliverable. For families with substantial company value where a single-tier succession advocate engagement is inadequate, we coordinate with your existing chartered accountant, company secretary, and wealth manager to build the full advisor network's response plan.
Q: What happens to the deceased Managing Director's ESOPs granted by the company? A: If the deceased was also an ESOP grantee (many founder-MDs are), the grant terms govern. Typical treatment: vested options can be exercised by the estate within a limited window (30-90 days per plan); unvested options usually lapse but some plans provide accelerated vesting on death. Read the ESOP plan document and coordinate exercise timing with the executor. This is often overlooked in the first 60 days after death, sometimes causing vested options to lapse unclaimed. See our companion piece on ESOP inheritance for employees for detail.
Q: If the founder-MD's Will names me as executor but I know nothing about running the company, what do I do? A: Your role as executor is to administer the estate, not to run the company. You need not personally take up any operating role. Engage professional counsel immediately, work with the company's existing board and senior management on operational continuity, and focus on your executor duties (asset inventory, debt settlement, distribution to beneficiaries). If the Will bequeaths company shares to specific persons, transfer those in due course. If the beneficiaries want operational succession advice, refer them to specialist counsel.
Q: Is probate mandatory to transfer the deceased MD's shares in the company? A: For Hindu, Sikh, Christian, and Parsi testators with property in Mumbai, Kolkata, or Chennai presidency limits, Section 213 ISA makes probate mandatory (see our Section 213 ISA guide). For property elsewhere, probate is technically optional but companies often insist on probate certificate for share transmission of substantial holdings. Small holdings can often be transmitted with succession certificate under Section 370 ISA.
Q: The founder was authorised signatory on all bank accounts. How do I unfreeze operations quickly? A: Present the death certificate and copy of the Will to the bank, request temporary board resolution authorising specific replacement signatories, and file that resolution with the bank immediately. Most Indian banks will honour a properly-passed emergency board resolution to unfreeze operations pending full succession formalities. For accounts with formal nomination in place, the nominee can operate on strength of death certificate + nomination.
Q: We are a family with 3 siblings inheriting equally under the founder's Will. Should we all be on the board? A: Not necessarily. Board composition should reflect who is best positioned to contribute to governance, not equal-treatment sentiment. A common structure: the operationally-active sibling as MD, one sibling on the board as director representing family interests, third sibling as shareholder without board seat but with information rights via the shareholders' agreement. This separates operational control from equity ownership.
Q: Can the family constitution override the Companies Act? A: No. The Companies Act is statutory law and cannot be contracted around by private agreement. But the family constitution can specify how the family will vote its collective shareholding, which members will hold specific roles, and how disputes among family will be resolved. Where the constitution provides for something the Companies Act permits (e.g., specific director appointment), it becomes effective through consistent shareholder voting.
Do private companies need to have a Managing Director? Private companies in India are not statutorily required to have a Managing Director under the Companies Act 2013. Section 203 mandates KMP for listed and specified public companies. Private companies often voluntarily appoint MDs for governance clarity and to enable formal delegation of executive authority.
What is the difference between a Managing Director and a Whole-Time Director? A Managing Director has substantial powers of company management under Section 196; a Whole-Time Director is a director in the whole-time employment of the company but without the MD's plenary authority. Both are KMP for statutory purposes.
How long does share transmission take after a founder's death? For uncontested cases with valid Will and proper probate/succession certificate documentation, share transmission typically takes 30-60 days at the company's registrar. For contested Wills or missing documentation, transmission can extend to 6-18 months.
Can a foreign national be a Managing Director of an Indian private company? Yes, subject to residency and work-permit conditions. Section 7 of the LLP Act requires at least one designated partner to be a resident of India (120+ days in previous FY). Companies Act 2013 has similar residency requirements for at least one director.
Is a Will drafted in the app.lawtarazoo.com Online Will service sufficient for a Managing Director? The Online Will (₹5,000) is appropriate for MDs of small companies with straightforward estate composition. For substantial company holdings, complex family situations, or where the MD role has specific succession considerations, the Personalised Will (₹25,000) tier is recommended.
This is general legal information, not legal advice. For your specific situation, consult a Law Tarazoo advocate. Business succession spans company law, personal law, tax law and inter-family agreements — coordinated advice from advocate + chartered accountant + company secretary is almost always warranted.
Start with the ₹5,000 Online Will — advocate-reviewed, delivered in your inbox in 30 minutes. Or book a 60-minute Personalised consult at ₹25,000.
Start My Will →
